|
The device has been received and device evaluation anticipated, but not yet begun.Upon completion of the device evaluation a supplemental report will be filed.Related mdrs for this event: 2029214-2020-00297.If information is provided in the future, a supplemental report will be issued.
|
|
D10: device available for evaluation - additional information g4.Date mfr rec ¿ additional information h2: type of follow up - device evaluation h3: device evaluated by manufacturer- additional information h6: codes updated the axium coil was returned for analysis.The implant coil was returned already detached from the pushwire.The pushwire was not returned.The implant coil appears to be in good condition.The implant coil detach element ball was found to be in good condition.Dried red residue (likely blood) was found on the detach element ball.The detach element ball was cleaned with alcohol to remove the dried residue.Based on the device analysis and reported information, the report of ¿premature detachment¿ was confirmed as the implant coil was found detached.Premature detachment can occur due to tortuous anatomy, coil is not retracted in a one-to-one motion with the implant pushwire during repositioning, pushwire rotation, user advances the coil against resistance, or a damaged pushwire.The patient¿s vessel anatomy was ¿normal¿, there was no reported resistance, the implant coil was not repositioned.The pushwire was not returned; therefore, any contributing factors could not be assessed.It is possible that the pushwire was rotated subsequently detaching the implant coil.However, the root cause could not be determined.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|